邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

甲状腺相关眼病基因多态性

李星辰,  辛论,  徐海燕,  胡芷柔,  李辉

downloadPDF
文章导航 > 协和医学杂志  > 2015 >  6(1): 52-55
李星辰, 辛论, 徐海燕, 胡芷柔, 李辉. 甲状腺相关眼病基因多态性[J]. 协和医学杂志, 2015, 6(1): 52-55. doi: 10.3969/j.issn.1674-9081.2015.01.011
引用本文: 李星辰, 辛论, 徐海燕, 胡芷柔, 李辉. 甲状腺相关眼病基因多态性[J]. 协和医学杂志, 2015, 6(1): 52-55. doi: 10.3969/j.issn.1674-9081.2015.01.011
shu

甲状腺相关眼病基因多态性

doi: 10.3969/j.issn.1674-9081.2015.01.011

  • 中国医学科学院 北京协和医学院 北京协和医院眼科, 北京 100730

详细信息
    通讯作者:

    李辉 电话:010-69156359, E-mail:huilixh@163.com

  • 中图分类号: R771.3;R394.3

    摘要
    • HTML全文
    • 参考文献(27)
  • [1] Bartalena L. The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy[J]. J Clin Endocrinol Metab, 2011, 96:592-599. doi:  10.1210/jc.2010-2329
    [2] Briceño CA, Gupta S, Douglas RS. Advances in the management of thyroid eye disease[J].Int Ophthalmol Clin, 2013, 53:93-101.
    [3] Stan MN, Bahn RS. Risk factors for development or deterioration of Graves' ophthalmopathy[J]. Thyroid, 2010, 20:777-783. doi:  10.1089/thy.2010.1634
    [4] Dolman PJ. Evaluating Graves' orbitopathy[J]. Best Pract Res Clin Endocrinol Metab, 2012, 26:229-248. doi:  10.1016/j.beem.2011.11.007
    [5] Khalilzadeh O, Noshad S, Rashidi A, et al. Graves' ophthalmopathy:a review of immunogenetics[J]. Curr Genomics, 2011, 12:564-575. doi:  10.2174/138920211798120844
    [6] Bednarczuk T, Gopinath B, Ploski R, et al. Susceptibility genes in Graves' ophthalmopathy:searching for a needle in a haystack?[J]. Clin Endocrinol, 2007, 67:3-19. doi:  10.1111/j.1365-2265.2007.02854.x
    [7] Wiersinga WM. Autoimmunity in Graves' ophthalmopathy:the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?[J]. J Clin Endocrinol Metab, 2011, 96:2386-2394. doi:  10.1210/jc.2011-0307
    [8] Iyer S, Bahn R. Immunopathogenesis of Graves' ophthalmopathy:the role of the TSh receptor[J]. Best Pract Res Clin Endocrinol Metab, 2012, 26:281-289. doi:  10.1016/j.beem.2011.10.003
    [9] Bahn RS. Graves' ophthalmopathy[J]. N Engl J Med, 2010, 362:726-738. doi:  10.1056/NEJMra0905750
    [10] Fife BT, Bluestone JA. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways[J]. Immunol Rev, 2008, 224:166-182. doi:  10.1111/j.1600-065X.2008.00662.x
    [11] Jacobson EM, Tomer Y. The genetic basis of thyroid autoimmunity[J]. Thyroid, 2007, 17:949-961. doi:  10.1089/thy.2007.0153
    [12] Yin X, Latif R, Bahn R, et al. Genetic profiling in Graves' disease:further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy[J]. Thyroid, 2012, 22:730-736. doi:  10.1089/thy.2012.0007
    [13] Allahabadia A, Heward JM, Nithiyananthan R, et al. MHC class Ⅱ region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease[J]. Lancet, 2001, 358:984-985. doi:  10.1016/S0140-6736(01)06125-6
    [14] Chistyakov DA, Savost'anov KV, Turakulov RI, et al.Genetic determinants of Graves disease[J]. Mol Genet Metab, 2000, 71:66-69. doi:  10.1006/mgme.2000.3042
    [15] Kula D, Bednarczuk T, Jurecka-Lubieniecka B, et al. Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves' disease:the impact of DRB1*07[J]. Thyroid, 2006, 16:447-453. doi:  10.1089/thy.2006.16.447
    [16] Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity:from epidemiology to etiology[J].J Autoimmun, 2008, 30:58-62. doi:  10.1016/j.jaut.2007.11.010
    [17] Du L, Yang J, Huang J. The associations between the polymorphisms in the CTLA-4 gene and the risk of Graves' disease in the Chinese population[J]. BMC Med Genet, 2013, 14:46. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=2420f457b9135346ec2fe695bdabe86f
    [18] 沈飞霞, 汪大望, 权金星. TAO CTLA-4基因外显子1 A/G多态性相关性研究[J].温州医学院院报, 2005, 35:356-358.
    [19] 陈光明, 沈飞霞. Graves眼病与CTLA-4基因第1外显子A49G多态性及临床特点的相关性研究[J].实用医学杂志, 2007, 23:642-644. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=syyxzz200705014
    [20] Yin X, Latif R, Bahn R, et al. Genetic profiling in Graves' disease:further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy[J]. Thyroid, 2012, 22:730-736. doi:  10.1089/thy.2012.0007
    [21] Gianoukakis AG, Khadavi N, Smith TJ. Cytokines, Graves' disease, and thyroid-associated ophthalmopathy[J]. Thyroid, 2008, 18:953-958. doi:  10.1089/thy.2007.0405
    [22] Kamizono S, Hiromatsu Y, Seki N, et al. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated oph-thalmopathy in Japanese[J]. Clin Endocrinol, 2000, 52:759-764. doi:  10.1046/j.1365-2265.2000.01011.x
    [23] 阎胜利, 王迎雪.甲状腺相关眼病与肿瘤坏死因子α基因启动子区-863C/A多态性相关性的初步研究[J].中华眼科杂志, 2005, 41:786-790. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhyk200509005
    [24] Bednarczuk T, Hiromatsu Y, Seki N, et al. Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy[J]. Hum Immunol, 2004, 65:632-639. doi:  10.1016/j.humimm.2004.02.033
    [25] Anvari M, Khalilzadeh O, Esteghamati A, et al.Genetic susceptibility to Graves' ophthalmopathy:the role of polymorphisms in proinflammatory cytokine genes[J]. Eye, 2010, 24:1058-1063. doi:  10.1038/eye.2009.244
    [26] Ploski R, Szymański K, Bednarczuk T. The genetic basis of Graves' disease[J]. Curr Genomics, 2011, 12:542-563. doi:  10.2174/138920211798120772
    [27] Brand OJ, Gough SC. Immunogenetic mechanisms leading to thyroid autoimmunity:recent advances in identifying susceptibility genes and regions[J]. Curr Genomics, 2011, 12:526-541.) doi:  10.2174/138920211798120790
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  160
  • HTML全文浏览量:  35
  • PDF下载量:  4
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-02-08
  • 刊出日期:  2015-01-30

目录

    /

    返回文章
    返回
    友情链接: 国家卫生健康委员会 北京协和医院 中国医学科学院 学术不端检测系统 国际知识资源总库 中国知网 术语在线 中国全科医学
    地址：北京市东城区帅府园1号 北京协和医院老楼7号楼
    3层302室 《协和医学杂志》编辑部
    电话：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    期刊网站版权所有：《协和医学杂志》编辑部
    京ICP备 11002662

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计

    x 关闭 永久关闭

    【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！